Literature DB >> 18308619

Overexpression of DNA repair genes is associated with metastasis: a new hypothesis.

Alain Sarasin1, Audrey Kauffmann.   

Abstract

Tumorigenesis is a multistep process, where it is believed that the transformation of normal cells into tumoral cells needs a succession of genetic and epigenetic changes, such as point mutations, chromosomal rearrangements, and changes in gene expression level. All these modifications are supposed to confer a selective advantage and to generate highly malignant cancer cells. Until recently, the same selection procedure of rare cells in the tumour mass was believed to be necessary for the metastatic process. Using gene expression profiling, several recent publications report that a gene expression signature could discriminate between primary tumours with high metastatic potentiality and poor clinical outcome, and primary tumours that are not going to metastasize. Analysis of the biological pathways associated with metastatic potential points to cell adhesion, angiogenesis, cell cycle regulation, initiation of DNA synthesis, and DNA repair. Analysing human primary malignant melanoma and various biological processes, we have shown that the overexpression of DNA repair pathways, particularly those involved in double-stand break repair and surveillance of the DNA replication forks, is associated with metastasis and poor patient survival [V. Winnepenninckx, V. Lazar, S. Michiels, P. Dessen, M. Stas, S.R. Alonso, M.F. Avril, P.L. Ortiz Romero, T. Robert, O. Balacescu, A.M. Eggermont, G. Lenoir, A. Sarasin, T. Tursz, J.J. van den Oord, A. Spatz, Gene expression profiling of primary cutaneous melanoma and clinical outcome, J. Natl. Cancer Inst. 98 (2006) 472-482]. These results, also found by analysing other types of human tumours, such as breast or bladder cancers, would clearly explain the high resistance of metastasis towards chemo- and radiotherapies. Our hypothesis is that genetic instability is absolutely necessary to go from normal cells to tumoral cells, but one needs some type of genetic stabilization, which can be obtained by overexpressing specific DNA repair genes, in order to produce primary tumour cells that are genetically stable enough to be able to invade and give rise to distant metastasis.

Entities:  

Mesh:

Year:  2008        PMID: 18308619     DOI: 10.1016/j.mrrev.2007.12.002

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  41 in total

1.  A hormone-DNA repair circuit governs the response to genotoxic insult.

Authors:  Jonathan F Goodwin; Matthew J Schiewer; Jeffry L Dean; Randy S Schrecengost; Renée de Leeuw; Sumin Han; Teng Ma; Robert B Den; Adam P Dicker; Felix Y Feng; Karen E Knudsen
Journal:  Cancer Discov       Date:  2013-09-11       Impact factor: 39.397

2.  Down-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features.

Authors:  Sophie Lehn; Nicholas P Tobin; Pontus Berglund; Kristina Nilsson; Andrew H Sims; Karin Jirström; Pirkko Härkönen; Rebecca Lamb; Göran Landberg
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

3.  DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells.

Authors:  Zhiyong Mao; Ying Jiang; Xiang Liu; Andrei Seluanov; Vera Gorbunova
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

Review 4.  The Eyes Absent proteins in development and disease.

Authors:  Emmanuel Tadjuidje; Rashmi S Hegde
Journal:  Cell Mol Life Sci       Date:  2012-09-13       Impact factor: 9.261

5.  Assessment of the XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro) and GSTP1 (Ile105Val) polymorphisms in the risk of cutaneous melanoma.

Authors:  Cristiane Oliveira; José Augusto Rinck-Junior; Gustavo Jacob Lourenço; Aparecida Machado Moraes; Carmen Silvia Passos Lima
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-09       Impact factor: 4.553

6.  Expression of proteins involved in epigenetic regulation in human cutaneous melanoma and peritumoral skin.

Authors:  Anatoly Uzdensky; Svetlana Demyanenko; Mikhail Bibov; Svetlana Sharifulina; Oleg Kit; Yury Przhedetski; Viktoria Pozdnyakova
Journal:  Tumour Biol       Date:  2014-05-22

7.  Inhibition of FoxM1-Mediated DNA Repair by Imipramine Blue Suppresses Breast Cancer Growth and Metastasis.

Authors:  Subapriya Rajamanickam; Subbarayalu Panneerdoss; Aparna Gorthi; Santosh Timilsina; Benjamin Onyeagucha; Dmytro Kovalskyy; Dmitri Ivanov; Martha A Hanes; Ratna K Vadlamudi; Yidong Chen; Alexander J Bishop; Jack L Arbiser; Manjeet K Rao
Journal:  Clin Cancer Res       Date:  2016-02-29       Impact factor: 12.531

Review 8.  Small-molecule inhibitors of DNA damage-repair pathways: an approach to overcome tumor resistance to alkylating anticancer drugs.

Authors:  Ajay Srinivasan; Barry Gold
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

9.  Identification of RECQ1-regulated transcriptome uncovers a role of RECQ1 in regulation of cancer cell migration and invasion.

Authors:  Xiao Ling Li; Xing Lu; Swetha Parvathaneni; Sven Bilke; Hongen Zhang; Saravanabhavan Thangavel; Alessandro Vindigni; Toshifumi Hara; Yuelin Zhu; Paul S Meltzer; Ashish Lal; Sudha Sharma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.

Authors:  Joseph R Evans; Shuang G Zhao; S Laura Chang; Scott A Tomlins; Nicholas Erho; Andrea Sboner; Matthew J Schiewer; Daniel E Spratt; Vishal Kothari; Eric A Klein; Robert B Den; Adam P Dicker; R Jeffrey Karnes; Xiaochun Yu; Paul L Nguyen; Mark A Rubin; Johann de Bono; Karen E Knudsen; Elai Davicioni; Felix Y Feng
Journal:  JAMA Oncol       Date:  2016-04       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.